Aspen Pharmacare replaces Woolworths in FTSE/JSE Top 40 index
What happened
Woolworths dropped out of the FTSE/JSE Top 40 index, with Aspen Pharmacare taking its position. The index, which tracks the exchange’s 40 largest companies by market value, saw the change take effect on September 21. The reshuffle was based on market value, with Woolworths ranking 45th and Aspen Pharmacare ranking 35th.
From riotimesonline.com
Why it matters
The index change follows a period of challenging performance for Woolworths, whose share price had slid 16 percent for the year by early August. In the year to June 28, 2026, Woolworths saw sales growth slip to 3.3 percent in the second half.
From riotimesonline.com
Who's involved
- Aspen PharmacareDrugmaker that gained a spot in the FTSE/JSE Top 40 index.
- WoolworthsSouth African retail company that exited the FTSE/JSE Top 40.
- Johannesburg Stock ExchangeStock exchange in Johannesburg, South Africa, that runs the index.
- FTSE RussellBritish provider of stock market indices that runs the FTSE/JSE Top 40.
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Aspen PharmacareSpeculative
Aspen Pharmacare might see increased investment and market visibility from gaining index membership.
Keep exploring
The entities involved
-
Aspen Pharmacare
multinational South African holding company for pharmaceutical concerns
Nothing else this week.
-
Woolworths
South African retail company
Nothing else this week.